Favipiravir drug trial approved against Covid-19, confirms CSIR
admin
Updated at:
01 Jan 1970 05:30 AM (IST)
Download ABP Live App and Watch All Latest Videos
View In App
A drug/medicine named Favipiravir has been given approval for trials to the Council of Scientific and Industrial Research (CSIR). According to the CSIR, the trial will start in a week. If this gets successful, it will help in treating coronavirus in India. The Drug Controller General has given permission for it.
Japan has authorized the antiviral drug remdesivir to treat coronavirus patients. Watch the report to know more.
Japan has authorized the antiviral drug remdesivir to treat coronavirus patients. Watch the report to know more.